Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis

  • Christian U. Huebbers*
  • , Femke Verhees
  • , Leonard Poluschkin
  • , Nadine C. Olthof
  • , Jutta Kolligs
  • , Oliver G. Siefer
  • , Mieke Henfling
  • , Frans C. S. Ramaekers
  • , Simon F. Preuss
  • , Dirk Beutner
  • , Julia Seehawer
  • , Uta Drebber
  • , Yueksel Korkmaz
  • , Wan L. Lam
  • , Emily A. Vucic
  • , Bernd Kremer
  • , Jens P. Klussmann
  • , Ernst-Jan M. Speel
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis'. Together they form a unique fingerprint.

Keyphrases

INIS

Immunology and Microbiology

Neuroscience